Brinker Capital Investments, LLC Eli Lilly & CO Transaction History

Brinker Capital Investments, LLC

$5.01 Billion
Q4 2022

A detailed history of Brinker Capital Investments, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 28,138 shares of LLY stock, worth $22.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

28,138

Previous 27,843 1.06%

Holding current value

$22.4 Million

Previous $9 Million 14.34%

% of portfolio

0.21%

Previous 0.19%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $94,857 - $110,527	295 Added 1.06%	28,138 $10.3 Million
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $355,183 - $404,768	1,198 Added 4.5%	27,843 $9 Million
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $646,374 - $758,939	-2,319 Reduced 8.01%	26,645 $8.64 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $102,090 - $126,872	-435 Reduced 1.48%	28,964 $8.29 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $1.19 Million - $1.48 Million	5,309 Added 22.04%	29,399 $8.12 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $966,303 - $1.25 Million	5,352 Added 28.56%	24,090 $5.53 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $3.34 Million - $4.33 Million	-20,345 Reduced 52.06%	18,738 $3.5 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $2.71 Million - $3.59 Million	20,769 Added 113.41%	39,083 $6.6 Million
Q3 2020 Dec 03, 2020	BUY	$146.22 - $169.13 $2.68 Million - $3.1 Million	18,314 New	18,314 $2.71 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $82,977 - $102,702	-697 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $1,601 - $1,742	-15 Reduced 2.11%	697 $78,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $10,192 - $11,897	-92 Reduced 11.44%	712 $79,000
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $89,493 - $105,340	804 New	804 $104,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account

Brinker Capital Investments, LLC Eli Lilly & CO Transaction History